13F-HR filed by Velan Capital Investment Management LP
Velan Capital Investment Management LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 49 holding rows worth $159,645,269.
- Accession
- 0001848809-26-000002
- Filer
- CIK 1848809
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 50 entries on the cover page, a total value of $159,645,269 stated on the cover page (in dollars after the unit check, H1), rows summing to $159,645,269 with VALUE read as dollars as filed, 13F file number 028-21996. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 100,781 | $32,470,630 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 2,834,652 | $14,768,537 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 512,160 | $12,757,906 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 446,255 | $10,259,402 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 492,893 | $10,020,515 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 583,333 | $9,327,495 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 77,000 | $8,573,950 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 8,753,290 | $7,003,507 | dollars as filed | |
| IMMIX BIOPHARMA INC | 45258H106 | COMMON STOCK | 740,000 | $6,741,400 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 1,720,000 | $4,712,800 | dollars as filed | |
| EDESA BIOTECH INC | 27966L306 | COM NEW | 827,500 | $4,327,825 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 700,000 | $3,885,000 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 2,099,652 | $3,422,433 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 250,000 | $3,015,000 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 185,122 | $2,763,871 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 352,000 | $2,548,480 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 540,000 | $2,538,000 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W207 | COM SHS | 471,559 | $2,494,547 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 2,668,395 | $2,338,047 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 750,000 | $2,287,500 | dollars as filed | |
| LYELL IMMUNOPHARMA INC COM NEW | 55083R203 | Stock | 102,000 | $2,046,120 | dollars as filed | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 285,710 | $1,851,401 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 91,123 | $1,782,366 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 294,643 | $1,054,822 | dollars as filed | |
| KAZIA THERAPEUTICS LTD | 48669G303 | SPONSORED ADS | 135,315 | $1,006,744 | dollars as filed | |
| NASUS PHARMA LTD | M7071P109 | ORD SHS | 359,390 | $797,846 | dollars as filed | |
| QUOIN PHARMACEUTICALS LTD | 74907L409 | SPONSORED ADS | 84,849 | $560,003 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 6,500 | $407,550 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 3,700 | $389,980 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 160,000 | $355,200 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 11,000 | $297,990 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 100,000 | $262,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 16,000 | $248,000 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 26,000 | $244,140 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 10,000 | $233,600 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P207 | COM NEW | 40,000 | $220,000 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 10,000 | $218,700 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 20,000 | $212,800 | dollars as filed | |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | COM | 25,000 | $161,000 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 80,000 | $156,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 20,000 | $153,000 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 33,000 | $148,500 | dollars as filed | |
| XILIO THERAPEUTICS INC | 98422T209 | COM | 14,285 | $120,137 | dollars as filed | |
| KALARIS THERAPEUTICS INC | 482929106 | COM | 18,000 | $103,860 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 73,000 | $90,520 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 30,000 | $86,700 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 15,000 | $83,550 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 45,000 | $72,900 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 70,000 | $22,995 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001848809-26-000002 | this filing | 2026-05-15 | acceptance time not in the bulk data set |